GSK to pay $3bn, plead guilty for promoting antidepressants
The largest health care fraud settlement in US history involves criminal and civil violations involving ten drugs. The company will also plead guilty for not reporting the safety
US-based gene therapy biotech Seawolf Therapeutics and Sanofi have signed a multi-target research partnership and exclusive licensing deal worth up to $1.2bn to develop treatments for bleeding disorders and other undisclosed indications.